Real-life efficacy

flutiform - real-life efficacy in asthma

In a non-interventional study, flutiform significantly improved Asthma Control Test™ scores after 1–6 months (p<0.001) versus baseline.1

Patients in this study reported improvements in:

  • Limitation on daily activities
  • Shortness of breath
  • Patient-rated asthma control
  • Night/early morning asthma symptoms
  • Rescue medication use

Patient numbers based on population at baseline and completers of study. At the time of the interim analysis 931 patients had completed month 1 follow-up, 761 month 3 follow-up and 567 month 6 follow-up.1 Interim analysis of 1,213 patients (safety population) and 986 patients (Full Analysis Population [FAP]). Study is planned to include 1,500 patients.1

flutiform offers treatment persistence for patients

In a retrospective real-world study, 92% of patients were still taking flutiform 12 months after it was prescribed2

Retrospective database study of the real-world dispensing of flutiform in the UK. Treatment persistence defined if one or more flutiform inhalers were dispensed within a three month period immediately preceding each analysis point at 6, 9 and 12 months, n=144.2

In another retrospective real-world study, 88% of patients successfully switched to flutiform from fluticasone propionate/salmeterol3,4

Retrospective database study of the real life effectiveness of flutiform in the UK. Change success defined as ≥70% of patients receiving ≥1 prescription of flutiform in the 6 months following therapy change (not including first prescription), n=164.3

1. Schmidt O et al. Poster Presentation P255. DGP Kongress 2015. 2. Roe R and Junor R. Poster Presentation. PCRS 2014. 3. Lim D et al. Abstract presented at International Primary Care Respiratory Group meeting, 21–24th May 2014, Athens, Greece. Abstract ORLB-008. 4. Hamill JM and Spyridon M. Abstract presented at the Primary Care Respiratory Society UK meeting, 26–27th September 2014, Hinckley, UK.

You are now leaving flutiform.com and moving to an external website independently operated and not managed by Mundipharma International Ltd. Mundipharma International Ltd assumes no responsibility for the site or its content.

If you do not wish to leave this site, click Cancel or click OK to continue.

OK Cancel